These findings suggest that in clinical conditions in which NCX function is reduced, such as diabetic cardiomyopathy, further NCX inhibition could trigger arrhythmias by reducing NCX function below the level required for balanced Ca2+ dynamics (Bogeholz et al., 2017). Here, TLX2 is linked to diabetic cardiomyopathy.